Reval

Reval
Providian House
16–18 Monument Street
London
EC3R 8AJ

T: +44 (0) 207 868 5240
F: +44 (0) 207 868 5241

Contacts
Brendan Nel Marketing Director EMEA (Brendan.nel@reval.com)
Peter Reynolds Vice President of Sales EMEA (Peter.reynolds@reval.com)
Michael Sokolow Managing Director EMEA (Michael.sokolow@reval.com)

Web Links
www.reval.com (http://www.reval.com)

Reval is the leading provider of derivative hedging and risk management solutions both as a Software-as-a-Service (Saas) offering via HedgeRX®, or on an outsourced basis via HedgeRx PlusTM. Reval also offers valuation services for those looking for independent marks-to-market. Reval’s clients benefit from complementary consulting and technology services including training, implementation assistance, business workflow analysis and interface development

HedgeRx® provides controlled and integrated processes that mitigate financial reporting risk under IAS 39, FAS 133 and other hedge accounting standards and related disclosure standards, such as IFRS 7. Under the Software-as-a-Service model, HedgeRx® is securely and efficiently delivered on its productiontested, n-tier platform RxCORE®.

Our platform provides front-to-back office processing of foreign exchange, interest rate, energy, metal and agricultural derivatives, allowing clients to perform end-to-end management of financial exposures and derivatives at any time from any global location with secure web access.

A fully hosted solution delivered over the Internet, HedgeRx® exemplifies the mix of cutting edge technology and financial experience that is making Reval the choice for a growing number of clients ranging from small corporations to the FTSE 250.

Reval’s solutions are supported by high quality financial professionals and certified public accountants that offer domain depth and responsive service. Reval clients benefit from enhanced hedging flexibility for a diverse range of instruments – reducing operating costs. Ultimately, this leads to a better and more predictable bottom line, as well as reduced risk of earning misstatements and regulatory non-compliance.